The expression levels of the glycolytic marker glucose transporter 1 (Glut1) were not significantly different between the CD8+ CAR-T cells isolated from the glioma tissues and those derived from the spleen (Figure 1B). Here, SLC2A1 is linked to central nervous system cancer.